The Application Notebook
One problem frequently encountered in LC–MS is the appearance of mass peaks, which appear totally unrelated to the samples run - "ghost" mass peaks. It is impossible to differentiate whether these signals come from an unknown component in the sample co-eluting with a known peak, or from an impurity in the mobile phase or from some residual contamination "bleeding" from the column.
One problem frequently encountered in LC–MS is the appearance of mass peaks, which appear totally unrelated to the samples run — "ghost" mass peaks. It is impossible to differentiate whether these signals come from an unknown component in the sample co-eluting with a known peak, or from an impurity in the mobile phase or from some residual contamination "bleeding" from the column.
Figure 1
To solve this problem, a three-step procedure is proposed for washing columns and choosing solvents for use in LC–MS measurements. This procedure also increases ionization efficiency and thereby increases both sensitivity and reproducibility of LC–MS measurements.
Step 1: Procedure for "Washing" the HPLC Column
A clean HPLC column is an essential pre-requisite for good LC–MS results. However, trace residues of organic compounds are nearly always present on reversed-phase HPLC columns. Residues may come from previously injected samples, from solvent impurities or from the silanes bonded to the silica surface. These residues are typically eluted very slowly from the column by the mobile phase. This phenomenon is called "column bleeding" and can give rise to unwanted background detector signals and can be very disturbing in LC–MS.
To minimize or even eliminate this "column bleeding", a simple procedure is to pump iso-propanol with 0.1% formic acid at room temperature for one hour through the column. For a column with 3 mm i.d., 0.5 mL/min flow-rate is appropriate. It is important that the column is not connected to the mass spectrometer to avoid contaminating the ion source.
Step 2: The Choice of Solvent Grade for the Mobile Phase
HPLC gradient or isocratic grade solvents are generally specified for use with UV detectors, sometimes with fluorescence detectors, but are not specified for use in LC–MS. Trace organic impurities may not absorb in UV at the wavelength used, but may be ionized in the mass spectrometer, thereby giving rise to background signals which appear in the mass spectra, making the spectra complex and difficult to interpret. Such impurities "compete" with the sample components in the ionization process and this competition causes "ionization suppression". The ionization efficiency is reduced and sensitivity is lost. Figure 2 shows a typical mass spectrum with low signal-to-noise ratio using standard reagent grade acetonitrile.
Figure 2
Figure 3 shows the same spectrum measured using LC–MS grade acetonitrile (Merck LiChrosolv hypergrade 1.00029). The ionization efficiency is increased more than 10-fold. This is a critical performance improvement. In addition, the intensity of background signals is negligible and all mass signals* can be directly correlated to the target compound, ethyl paraben.
Figure 3
*(mass 167.1 = M+H, mass 189.0 = M+Na, mass 139.1 = fragment protonated p-hydroxybenzoic acid, mass 121.2 = protonated fragment)
Step 3: Equilibrating the HPLC Column
Finally the column must be re-equilibrated with the mobile phase. Best results are obtained when two blind gradients (without sample injection) are run prior to analysing samples.
By application of a simple column washing procedure and use of LC–MS specified solvent, LC–MS results can be improved in three ways:
The method has been verified with Chromolith RP-18e (monolithic silica) and Purospher STAR RP-18e 3 μm and 5 μm HPLC columns.
1. Solvents available from Merck in LC–MS specified quality: Acetonitrile — LiChrosolv hypergrade 1.00029 Methanol — LiChrosolv hypergrade 1.06035
2. Chromolith RP-18e columns are made from high-purity metal-free monolithic silica and used for fast LC–MS Purospher STAR RP-18e columns are made from high-purity metal-free 3 μm and 5 μm silica particles
Alexander Kraus, Rod McIlwrick, Gisela Jung and Ines Hädrich, Merck KGaA, Darmstadt, Germany.
Merck KGaA
Frankfurter Strasse 250, D-64293 Darmstadt, Germany
Fax: +49 6151 72 6080
E-mail: chromatography@merck.de
Websites: www.merck.de, www.chromatography.merck.de.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
GPCRs – The Biological Traffic Modulator: Chromatographic Analysis of Peptides in the GI Tract
January 20th 2025The G protein-coupled receptors (GPCR) are found throughout the entire body and have shown significance in the development of new therapeutic treatments. Isolation of seven classic GRPC peptides initiating in the GI tract highlights the benefits of using the polymer-based PRP-3, a reversed-phase resin. The covalent bonds found in the PRP-3 exhibit advantageous interactions between the biological π bonds found in the peptides and the available aromatic benzyl rings of the resin.